Literature DB >> 32656949

DYNC1H1-related disorders: A description of four new unrelated patients and a comprehensive review of previously reported variants.

Sonia Amabile1, Lauren Jeffries1, James M McGrath2, Weizhen Ji1, Michele Spencer-Manzon2, Hui Zhang2, Saquib A Lakhani1.   

Abstract

Heterozygous variants in the DYNC1H1 gene have been associated chiefly with intellectual disability (ID), malformations in cortical development (MCD), spinal muscular atrophy (SMA), and Charcot-Marie-Tooth axonal type 20 (CMT), with fewer reports describing other intersecting phenotypes. To better characterize the variable syndromes associated with DYNC1H1, we undertook a detailed analysis of reported patients in the medical literature through June 30, 2019. In sum we identified 200 patients from 143 families harboring 103 different DYNC1H1 variants, and added reports for four unrelated patients identified at our center, three with novel variants. The most common features associated with DYNC1H1 were neuromuscular (NM) disease (largely associated with variants in the stem domain), ID with MCD (largely associated with variants in the motor domain), or a combination of these phenotypes. Despite these trends, exceptions are noted throughout. Overall, DYNC1H1 is associated with variable neurodevelopmental and/or neuromuscular phenotypes that overlap. To avoid confusion DYNC1H1 disorders may be best categorized at this time by more general descriptions rather than phenotype-specific nomenclature such as SMA or CMT. We therefore propose the terms: DYNC1H1-related NM disorder, DYNC1H1-related CNS disorder, and DYNC1H1-related combined disorder. Our single center's experience may be evidence that disease-causing variants in this gene are more prevalent than currently recognized.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  DYNC1H1; intellectual disability; malformations in cortical development; neuromuscular; overlap; spinal muscular atrophy

Mesh:

Substances:

Year:  2020        PMID: 32656949     DOI: 10.1002/ajmg.a.61729

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.578


  5 in total

1.  A retrospective cohort analysis of the Yale pediatric genomics discovery program.

Authors:  Samir Al-Ali; Lauren Jeffries; E Vincent S Faustino; Weizhen Ji; Emily Mis; Monica Konstantino; Cynthia Zerillo; Yong-Hui Jiang; Michele Spencer-Manzon; Allen Bale; Hui Zhang; Julie McGlynn; James M McGrath; Thierry Tremblay; Nina N Brodsky; Carrie L Lucas; Richard Pierce; Engin Deniz; Mustafa K Khokha; Saquib A Lakhani
Journal:  Am J Med Genet A       Date:  2022-07-28       Impact factor: 2.578

Review 2.  Whole-exome sequencing identifies a novel de novo variant in DYNC1H in a patient with intractable epilepsy.

Authors:  Caihong Ji; Dengchang Wu; Kang Wang
Journal:  Neurol Sci       Date:  2022-01-28       Impact factor: 3.830

Review 3.  A novel variant in DYNC1H1 could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Alexios-Fotios A Mentis; Dimitrios Vlachakis; Eleni Papakonstantinou; Ioannis Zaganas; George P Patrinos; George P Chrousos; Efthimios Dardiotis
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

4.  De novo DYNC1H1 mutation causes infantile developmental and epileptic encephalopathy with brain malformations.

Authors:  Tangfeng Su; Yu Yan; Qingqing Hu; Yan Liu; Sanqing Xu
Journal:  Mol Genet Genomic Med       Date:  2022-01-31       Impact factor: 2.183

5.  Common and Unique Genetic Background between Attention-Deficit/Hyperactivity Disorder and Excessive Body Weight.

Authors:  Monika Dmitrzak-Weglarz; Elzbieta Paszynska; Karolina Bilska; Paula Szczesniewska; Ewa Bryl; Joanna Duda; Agata Dutkiewicz; Marta Tyszkiewicz-Nwafor; Piotr Czerski; Tomasz Hanc; Agnieszka Slopien
Journal:  Genes (Basel)       Date:  2021-09-13       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.